ID

39511

Description

Prospective Observation of Cardiac Safety With Proteasome Inhibition; ODM derived from: https://clinicaltrials.gov/show/NCT02178579

Lien

https://clinicaltrials.gov/show/NCT02178579

Mots-clés

Versions (1)
  1. 21/01/2020 21/01/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

21 janvier 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Heart Failure NCT02178579

Anglais

Eligibility Heart Failure NCT02178579

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsed multiple myeloma at any time-point in treatment course and planning to start a proteasome inhibitor-based therapy as part of standard care
Description

Recurrent Multiple Myeloma | Proteasome inhibitor Planned | Part of Standard therapy

Type de données

boolean

Alias
UMLS CUI [1]
C1370446
UMLS CUI [2,1]
C1443643
UMLS CUI [2,2]
C1301732
UMLS CUI [3,1]
C1292711
UMLS CUI [3,2]
C2936643
received at least one prior line of therapy for multiple myeloma (induction therapy followed by stem cell transplant and consolidation/maintenance therapy will be considered as one line of therapy)
Description

Treatment Course Quantity Multiple Myeloma | Neoadjuvant Therapy | Stem cell transplant | Consolidation therapy | Maintenance therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0750729
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0026764
UMLS CUI [2]
C0600558
UMLS CUI [3]
C1504389
UMLS CUI [4]
C1511484
UMLS CUI [5]
C0677908
males and females ≥ 18 years of age
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
able to provide written informed consent in accordance with federal, local, and institutional guidelines
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
poems syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
Description

POEMS Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0085404
known or suspected al amyloidosis, secondary amyloidosis or cardiac amyloidosis
Description

Primary amyloidosis | Primary amyloidosis Suspected | Reactive systemic amyloidosis | Reactive systemic amyloidosis Suspected | Cardiac amyloidosis | Cardiac amyloidosis Suspected

Type de données

boolean

Alias
UMLS CUI [1]
C0268381
UMLS CUI [2,1]
C0268381
UMLS CUI [2,2]
C0750491
UMLS CUI [3]
C0221014
UMLS CUI [4,1]
C0221014
UMLS CUI [4,2]
C0750491
UMLS CUI [5]
C0268407
UMLS CUI [6,1]
C0268407
UMLS CUI [6,2]
C0750491
plasma cell leukemia (> 2.0 × 109/l circulating plasma cells by standard differential)
Description

Leukemia, Plasma Cell | Circulating Plasma Cell Measurement Differential quality

Type de données

boolean

Alias
UMLS CUI [1]
C0023484
UMLS CUI [2,1]
C3811668
UMLS CUI [2,2]
C0242485
UMLS CUI [2,3]
C0443199
waldenström macroglobulinemia
Description

Waldenstrom Macroglobulinemia

Type de données

boolean

Alias
UMLS CUI [1]
C0024419
myelodysplastic syndrome
Description

MYELODYSPLASTIC SYNDROME

Type de données

boolean

Alias
UMLS CUI [1]
C3463824
history of mi within the last 3 months
Description

Myocardial Infarction

Type de données

boolean

Alias
UMLS CUI [1]
C0027051
symptomatic unstable cardiac arrhythmia requiring treatment in the past 3 months
Description

Cardiac Arrhythmia Symptomatic Unstable | Treatment required

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0443343
UMLS CUI [2]
C0332121
class 3 or 4 new york heart association heart failure in the past 3 months
Description

Heart failure New York Heart Association Classification

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
any other clinically significant medical disease or condition that, in the investigator's opinion, may interfere with protocol adherence or a subject's ability to give informed consent
Description

Disease Interferes with Protocol Compliance | Medical condition Interferes with Protocol Compliance | Disease Interferes with Informed Consent | Medical condition Interferes with Informed Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0525058
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0021430
UMLS CUI [4,1]
C3843040
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0021430
Retour au début de la page

Similar models

Eligibility Heart Failure NCT02178579

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Recurrent Multiple Myeloma | Proteasome inhibitor Planned | Part of Standard therapy
Item
relapsed multiple myeloma at any time-point in treatment course and planning to start a proteasome inhibitor-based therapy as part of standard care
boolean
C1370446 (UMLS CUI [1])
C1443643 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C1292711 (UMLS CUI [3,1])
C2936643 (UMLS CUI [3,2])
Treatment Course Quantity Multiple Myeloma | Neoadjuvant Therapy | Stem cell transplant | Consolidation therapy | Maintenance therapy
Item
received at least one prior line of therapy for multiple myeloma (induction therapy followed by stem cell transplant and consolidation/maintenance therapy will be considered as one line of therapy)
boolean
C0087111 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0026764 (UMLS CUI [1,4])
C0600558 (UMLS CUI [2])
C1504389 (UMLS CUI [3])
C1511484 (UMLS CUI [4])
C0677908 (UMLS CUI [5])
Age
Item
males and females ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
able to provide written informed consent in accordance with federal, local, and institutional guidelines
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
POEMS Syndrome
Item
poems syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
boolean
C0085404 (UMLS CUI [1])
Primary amyloidosis | Primary amyloidosis Suspected | Reactive systemic amyloidosis | Reactive systemic amyloidosis Suspected | Cardiac amyloidosis | Cardiac amyloidosis Suspected
Item
known or suspected al amyloidosis, secondary amyloidosis or cardiac amyloidosis
boolean
C0268381 (UMLS CUI [1])
C0268381 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0221014 (UMLS CUI [3])
C0221014 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0268407 (UMLS CUI [5])
C0268407 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
Leukemia, Plasma Cell | Circulating Plasma Cell Measurement Differential quality
Item
plasma cell leukemia (> 2.0 × 109/l circulating plasma cells by standard differential)
boolean
C0023484 (UMLS CUI [1])
C3811668 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
C0443199 (UMLS CUI [2,3])
Waldenstrom Macroglobulinemia
Item
waldenström macroglobulinemia
boolean
C0024419 (UMLS CUI [1])
MYELODYSPLASTIC SYNDROME
Item
myelodysplastic syndrome
boolean
C3463824 (UMLS CUI [1])
Myocardial Infarction
Item
history of mi within the last 3 months
boolean
C0027051 (UMLS CUI [1])
Cardiac Arrhythmia Symptomatic Unstable | Treatment required
Item
symptomatic unstable cardiac arrhythmia requiring treatment in the past 3 months
boolean
C0003811 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
C0332121 (UMLS CUI [2])
Heart failure New York Heart Association Classification
Item
class 3 or 4 new york heart association heart failure in the past 3 months
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Disease Interferes with Protocol Compliance | Medical condition Interferes with Protocol Compliance | Disease Interferes with Informed Consent | Medical condition Interferes with Informed Consent
Item
any other clinically significant medical disease or condition that, in the investigator's opinion, may interfere with protocol adherence or a subject's ability to give informed consent
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0021430 (UMLS CUI [3,3])
C3843040 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial